Memphis clinic created to care for children and adolescents diagnosed with melanomaJuly 30, 2020MelanomaPediatrics
CCC19, other registries help define COVID/cancer landscapeJuly 27, 2020Patient & Survivor CareLung CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersCOVID-19 UpdatesGastroenterologyGenitourinary Cancer
FDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Personalized cancer vaccine may enhance checkpoint inhibitor activityJune 25, 2020ImmunotherapyBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMelanoma
Adding low-dose ipi to pembro seems safer, still effective for advanced melanomaJune 12, 2020Melanoma
Can an app guide cancer treatment decisions during the pandemic?June 9, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastroenterologyGenitourinary CancerGynecologic Cancer
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseasesJune 8, 2020Melanoma
‘A good and peaceful death’: Cancer hospice during the pandemicJune 5, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Germline testing in advanced cancer can lead to targeted treatmentJune 3, 2020Mixed TopicsBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
